$CLNN 4 SEC Filings

Filed On	Filing
21 Oct 2026	Form 4: Etherington Robert Dee, Director Granted 55,000 stock option
21 Oct 2026	Form 4: Mortenson Mark, Chief Science Officer Granted 30,000 stock option
21 Oct 2026	Form 4: Brown Morgan R, Chief Financial Officer Granted 20,000 stock option
18 Sep 2026	Form 4: Matlin David J, Director Received 434,451 shares as a grant or award ($1.42M)
18 Sep 2026	Form 4: Etherington Robert Dee, Director Received 15,244 shares as a grant or award ($50K)
18 Sep 2026	Form 4: Mosca Alison, Director Received 198,171 shares as a grant or award ($650K)
14 Aug 2026	Form 4: Kiernan Matthew, Director Granted 3,195 stock option
14 Aug 2026	Form 4: Desai Arjun Jj, Director Granted 3,674 stock option
14 Aug 2026	Form 4: Mosca Alison, Director Granted 4,872 stock option
14 Aug 2026	Form 4: Matlin David J, Director Granted 6,230 stock option
14 Aug 2026	Form 4: Jacobovitz Shalom, Director Granted 4,752 stock option
14 Aug 2026	Form 4: Gay Jonathon, Director Granted 3,794 stock option
14 Aug 2026	Form 4: McLaughlin Vallerie, Director Granted 3,514 stock option
14 Aug 2026	Form 4: Wilcox Reed N, Director Granted 3,514 stock option
06 Aug 2026	Form 4: Ugwumba Chidozie, 10% owner Disposed of 375,000 Warrant to Purchase Common Stock (Tranche B, $30.00 strike) (Other Transaction) · Disposed of 424,358 Common Stock Purchase Warrant ($4.82 strike) (Other Transaction)
15 Jun 2026	Form 4: Mortenson Mark, Chief Science Officer Granted 45,000 stock option
15 Jun 2026	Form 4: Etherington Robert Dee, Director Granted 65,000 stock option
15 Jun 2026	Form 4: Brown Morgan R, Chief Financial Officer Granted 15,000 stock option
22 May 2026	Form 4: McLaughlin Vallerie, Director Granted 3,564 stock option
22 May 2026	Form 4: Desai Arjun Jj, Director Granted 3,658 stock option

Comments